Clik here to view.
Umirolimus, Biolimus
Umirolimus, Biolimus Biosensors (Originator) 40 -O-[(2′-ethoxy) ethyl]rapamycin...
View ArticleClik here to view.
TACROLIMUS
Tacrolimus, Fujimycin 104987-11-3 CAS, 804.0182, C44H69NO12 Astagraf XL FK 506 FR 900506 FR900506 LCP-Tacro Prograf Protopic Tacrolimus Tacrolimus hydrate Tsukubaenolide hydrate UNII-WM0HAQ4WNM...
View ArticleClik here to view.
Octreotide اکترئتید For treatment of acromegaly and reduction of side effects...
Octreotide (D)-Phe-Cys-Phe-(D)-Trp-Lys-Thr-Cys-Thr-ol....
View ArticleClik here to view.
FDA Implementation of eCTD Module 1 Update Scheduled for Q4 2014
Originally posted on DRUG REGULATORY AFFAIRS INTERNATIONAL: The biggest change in the history of eCTD is one step closer to implementation. According to a notice posted this week on its website, the...
View ArticleClik here to view.
Ann-Teresa Cusenza…..Managing Editor, Orphan Druganaut Blog
Ann-Teresa Cusenza It is a great pleasure to write about ANN…. I read her blog everyday………………………. Medical Information Specialist | Medical Librarian | Managing Editor, Orphan Druganaut Blog Greater...
View ArticleClik here to view.
FDA Approves First Device to Prevent Migraines
TUESDAY March 11, 2014, 2014 — The U.S. Food and Drug Administration on Tuesday approved the first device aimed at preventing migraines. The device, called Cefaly, is a headband-like device that runs...
View ArticleClik here to view.
MEPOLIZUMAB….GSK to file severe asthma drug by year end
The first non-inhaled treatment for a difficult-to-treat form of severe asthma is getting closer to market after GlaxoSmithKline said it would initiate global filings for the drug at the end of this...
View ArticleClik here to view.
EMA publishes New Process Validation Guideline
EMA publishes New Process Validation Guideline After the publication of the Annex 15 draft at the beginning of February 2014, the EMA made a move towards the revision of its process validation...
View ArticleClik here to view.
FDA Asked To Improve Approval Processes For Orphan Drugs
Originally posted on DRUG REGULATORY AFFAIRS INTERNATIONAL: Lawmakers appealed to FDA Commissioner Margaret Hamburg to improve consistency of approval processes for orphan drugs , in a letter...
View ArticleClik here to view.
Onion extract slows colon cancer growth just as effectively as chemo drug
(NaturalNews) Researchers have just discovered that flavonoids extracted from common onions slow the rate of colon cancer growth in mice just as effectively as a chemotherapy drug. And while the mice...
View ArticleClik here to view.
Nemonoxacin….TaiGen’s pneumonia antibiotic Taigexyn 奈诺沙星 gets marketing...
Nemonoxacin 奈诺沙星 378746-64-6 CAS TG-873870 C20-H25-N3-O4 371.4345 WARNER CHILCOTT ORIGINATOR CLINICAL TRIALS http://clinicaltrials.gov/search/intervention=Nemonoxacin...
View ArticleClik here to view.
MIFEPRISTONE
Mifepristone Abortifacient. CAS: 84371-65-3 (11b,17b)-11-[4-(Dimethylamino)phenyl]-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one 17β-hydroxy-11β-(4-dimethylaminophenyl)-17α (Propa-1 ,2-dienyl)...
View ArticleClik here to view.
NEW DRUG APPROVALS bY DR ANTHONY CRASTO WILL TOUCH 2 LAKH VIEWS THIS MONTH
NEW DRUG APPROVALS WILL TOUCH 2 LAKH VIEWS THIS MONTH THANKS FOR YOUR SUPPORT http://newdrugapprovals.org/ 2 LAKH VIEWS SOON DR ANTHONY MELVIN CRASTO MY BLOGS……… ALL ABOUT DRUGS, WORLD DRUG TRACKER,...
View ArticleClik here to view.
Amgen Drug Evolocumab Hits Endpoint of Cholesterol Reduction
Amgen announced that the Phase 3 TESLA (Trial Evaluating PCSK9 Antibody in Subjects with LDL Receptor Abnormalities) trial evaluating evolocumab met its primary endpoint of the percent reduction from...
View ArticleClik here to view.
Vatiquinone, Epi 743 Fredrich’s ataxia drug, Edison Pharmaceuticals lead drug...
Vatiquinone 1213269-98-7 CAS , MW440.6636, C29 H44 O3 Reverses visual loss due to retinal ganglion degeneration. 2,5-Cyclohexadiene-1,4-dione,...
View ArticleClik here to view.
NADIFLOXACIN, Jinofloxacin
Nadifloxacin OPC-7251, Nadixa, Nadoxin, Acuatim CAS 124858-35-1 9-Fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid...
View ArticleClik here to view.
PICLAMILAST
PICLAMILAST An antiasthmatic agent and phosphodiesterase 4 inhibitor. 144035-83-6 SANOFI 3-(Cyclopentyloxy)-N-(3,5-dichloro-4-pyridinyl)-4-methoxybenzamide...
View ArticleClik here to view.
The U.S. FDA approved Impavido (miltefosine) to treat a tropical disease...
MILTEFOSINE 2-(hexadecoxy-oxido-phosphoryl)oxyethyl-trimethyl-azanium 58066-85-6 Hexadecylphosphocholine, Miltex, HDPC, HePC, Hexadecylphosphorylcholine, 58066-85-6, Miltefosina, Miltefosinum,...
View ArticleClik here to view.
Orphan Drugs: FDA Approval For Tropical Disease
Originally posted on Orphan Druganaut Blog: The FDA announces on March 19th the approval of Impavido (Miltefosine), an oral medicine for the treatment of the tropical disease Leishmaniasis....
View ArticleClik here to view.
Cabazitaxel
Cabazitaxel For treatment of patients with hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing treatment regimen....
View Article